Waheed Ullah Hafiz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Waheed Ullah Hafiz has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Sabi Ur Rehman
Department of Pharmacy, Faculty of Natural Sciences, Forman Christian College (A Chartered University), Lahore 54600, Pakistan
2 shared publications - Amir Zeb
Faculty of Pharmaceutical Sciences Abasyn University Peshawar Pakistan abasyn.edu.pk
1 shared publication - Daud Ur Rehman
Department of Pharmacy, Forman Christian College (A Chartered University), Lahore, Pakistan
1 shared publication - Fazal Ur Rehman
Gomal Center of Pharmaceutical Sciences Faculty of Pharmacy Gomal University Dera Ismail Khan Pakistan gu.edu.pk
1 shared publication - Hamid Saeed
Punjab University College of Pharmacy, University of the Punjab, Lahore, Pakistan
1 shared publication - Laiba Arshad
Department of Pharmacy, Forman Christian College (A Chartered University), Lahore, Pakistan
1 shared publication
Latest Publications
- Open Access
- 23 September 2026
- Published by Ghalib University, Herat Branch in Ghalib Medical Journal
- Vol. 2 (3) , 183
Prevalence of Upper Gastrointestinal Bleeding in Paktia Regional Hospital (Paktia, 2024 – 2025)
Background and Objective: Upper gastrointestinal bleeding (UGIB) is a common medical emergency originating from the esophagus, stomach, or duodenum. Local evidence is important for timely diagnosis, referral, and management in provincial hospitals. This study aimed to determine the prevalence, demographic characteristics, clinical presentations, and etiological patterns of UGIB among admitted patients at Paktia Regional Hospital. Method: A descriptive cross-sectional study was conducted using medical records of patients admitted to the Internal Medicine Department from 2024 to 2025. Patients aged above 18 years with a diagnosis of UGIB were included. Data were extracted through a structured data-collection form and analyzed using Microsoft Excel 2016. Findings/ Result: Among 1,085 admitted patients, 31 were diagnosed with UGIB, giving a prevalence of 2.86%. Eighteen patients (58.07%) were male and 13 (41.93%) were female. The highest number of cases occurred in the 51–60-year age group. Among 12 patients who underwent endoscopy, peptic ulcer disease was the leading cause, accounting for 4 cases (33.33%). The most common clinical presentations were hematemesis, abdominal pain, and melena. Conclusion: UGIB in this study was more frequent among middle-aged men, and peptic ulcer disease was the most common endoscopic cause. Strengthening endoscopy services, improving medical record documentation, and preventing unsafe NSAID use may improve early diagnosis and management.
- 23 September 2026
- Published by Ghalib University, Herat Branch in Ghalib Medical Journal
- Vol. 2 (3) , 183
Open AccessPrevalence of Upper Gastrointestinal Bleeding in Paktia Regional Hospital (Paktia, 2024 – 2025)
Background and Objective: Upper gastrointestinal bleeding (UGIB) is a common medical emergency originating from the esophagus, stomach, or duodenum. Local evidence is important for timely diagnosis, referral, and management in provincial hospitals. This study aimed to determine the prevalence, demographic characteristics, clinical presentations, and etiological patterns of UGIB among admitted patients at Paktia Regional Hospital. Method: A descriptive cross-sectional study was conducted using medical records of patients admitted to the Internal Medicine Department from 2024 to 2025. Patients aged above 18 years with a diagnosis of UGIB were included. Data were extracted through a structured data-collection form and analyzed using Microsoft Excel 2016. Findings/ Result: Among 1,085 admitted patients, 31 were diagnosed with UGIB, giving a prevalence of 2.86%. Eighteen patients (58.07%) were male and 13 (41.93%) were female. The highest number of cases occurred in the 51–60-year age group. Among 12 patients who underwent endoscopy, peptic ulcer disease was the leading cause, accounting for 4 cases (33.33%). The most common clinical presentations were hematemesis, abdominal pain, and melena. Conclusion: UGIB in this study was more frequent among middle-aged men, and peptic ulcer disease was the most common endoscopic cause. Strengthening endoscopy services, improving medical record documentation, and preventing unsafe NSAID use may improve early diagnosis and management.
- Open Access
- 1 January 2026
- Published by Wiley in PPAR Research
- Vol. 2026 (1)
Phytochemicals at the PPAR–NF‐ κ B Interface: A Structured Narrative Review of Receptor Pharmacology, Inflammatory Signaling, and Translational Barriers
Background: The peroxisome proliferator‐activated receptors (PPARs) and nuclear factor‐ κ B (NF‐ κ B) signaling axis serves as master molecular interface governing metabolic homeostasis and inflammatory resolution. Dysregulated reciprocal repression between PPAR‐ α / γ and NF‐ κ B contributes to chronic inflammatory diseases, metabolic syndrome, and malignancy. Synthetic full agonists (e.g., thiazolidinediones and fibrates) are associated with clinical liabilities including adipogenesis, fluid retention, hepatotoxicity, and cardiovascular adverse effects, underscoring the need for safer modulators. Objective and Rationale: This structured narrative review provides a rigorous mechanistic synthesis of plant derived phytochemicals with selective PPAR modulator (SPPARM) like pharmacology. We elucidate how distinct chemical classes may achieve targeted NF‐ κ B transrepression with reduced transcriptional liability, summarize available ligand receptor binding data, and critically evaluate translational hurdles. Methods: A structured narrative review was conducted using a systematic style literature search across PubMed/MEDLINE, Scopus, and Web of Science from January 2000 through March 2026. In line with PRISMA 2020 principles for transparent reporting, original research articles were prioritized according to evidence type (clinical, preclinical, in vivo, and in vitro/in silico), with emphasis on pharmacodynamic metrics, binding kinetics (K i , EC 50 , and IC 50 ), receptor dependency validation (knockout, antagonism), and pharmacokinetic data. Results: Chemically diverse phytochemicals including flavonoids, neolignans, stilbenoids and terpenoids exhibit partial or subtype selective PPAR agonism in reporter and binding assays. Mechanistically, many favor anti‐inflammatory transrepression over full coactivator‐dependent transactivation, with evidence for corepressor recruitment and inhibition of NF‐ κ B nuclear translocation in selected models. However, integrated analysis reveals a persistent disconnect between submicromolar in vitro potency and negligible systemic exposure of free parent compound (low C max , extensive glucuronidation/sulfation), compounded by frequent reliance on unvalidated docking simulations and PPAR‐independent NF‐ κ B inhibition. Conclusion: Phytochemicals with SPPARM‐like pharmacology represent a promising but unvalidated paradigm for nonsteroidal inflammation control. Realizing their potential will require next‐generation delivery systems (e.g., liposomes, nanoemulsions, and cyclodextrin complexes), mandatory genetic or pharmacological receptor validation, and biomarker‐driven clinical trials that document target engagement at achievable human exposure levels.
- 1 January 2026
- Published by Wiley in PPAR Research
- Vol. 2026 (1)
Open AccessPhytochemicals at the PPAR–NF‐ κ B Interface: A Structured Narrative Review of Receptor Pharmacology, Inflammatory Signaling, and Translational Barriers
Background: The peroxisome proliferator‐activated receptors (PPARs) and nuclear factor‐ κ B (NF‐ κ B) signaling axis serves as master molecular interface governing metabolic homeostasis and inflammatory resolution. Dysregulated reciprocal repression between PPAR‐ α / γ and NF‐ κ B contributes to chronic inflammatory diseases, metabolic syndrome, and malignancy. Synthetic full agonists (e.g., thiazolidinediones and fibrates) are associated with clinical liabilities including adipogenesis, fluid retention, hepatotoxicity, and cardiovascular adverse effects, underscoring the need for safer modulators. Objective and Rationale: This structured narrative review provides a rigorous mechanistic synthesis of plant derived phytochemicals with selective PPAR modulator (SPPARM) like pharmacology. We elucidate how distinct chemical classes may achieve targeted NF‐ κ B transrepression with reduced transcriptional liability, summarize available ligand receptor binding data, and critically evaluate translational hurdles. Methods: A structured narrative review was conducted using a systematic style literature search across PubMed/MEDLINE, Scopus, and Web of Science from January 2000 through March 2026. In line with PRISMA 2020 principles for transparent reporting, original research articles were prioritized according to evidence type (clinical, preclinical, in vivo, and in vitro/in silico), with emphasis on pharmacodynamic metrics, binding kinetics (K i , EC 50 , and IC 50 ), receptor dependency validation (knockout, antagonism), and pharmacokinetic data. Results: Chemically diverse phytochemicals including flavonoids, neolignans, stilbenoids and terpenoids exhibit partial or subtype selective PPAR agonism in reporter and binding assays. Mechanistically, many favor anti‐inflammatory transrepression over full coactivator‐dependent transactivation, with evidence for corepressor recruitment and inhibition of NF‐ κ B nuclear translocation in selected models. However, integrated analysis reveals a persistent disconnect between submicromolar in vitro potency and negligible systemic exposure of free parent compound (low C max , extensive glucuronidation/sulfation), compounded by frequent reliance on unvalidated docking simulations and PPAR‐independent NF‐ κ B inhibition. Conclusion: Phytochemicals with SPPARM‐like pharmacology represent a promising but unvalidated paradigm for nonsteroidal inflammation control. Realizing their potential will require next‐generation delivery systems (e.g., liposomes, nanoemulsions, and cyclodextrin complexes), mandatory genetic or pharmacological receptor validation, and biomarker‐driven clinical trials that document target engagement at achievable human exposure levels.
- Open Access
- 28 April 2025
- Published by University of Management and Technology in Currents in Pharmaceutical Research
- Vol. 3 (1) , 28-51
Pharmacognostic, Phytochemical, and DNA Protection Assays of Eclipta alba, Ageratum conyzoides, Calendula officinalis, and Conyza bonariensis
Asteraceae is the most famous family of ornamental flowering plants. Most of the plants included in this family have medicinal properties. The current research aimed to investigate the pharmacognostic and phytochemical standards of Eclipta alba L., Ageratum conyzoides L., Calendula officinalis L., and Conyza bonariensis L. to ensure their purity, safety, and efficacy as medicinal agents. The investigated parameters included pharmacognostic characterization, that is, powder microscopy, preliminary phytochemical analysis, physicochemical analysis, and in vitro DNA protection assay. The pharmacognostic characteristics evaluated via microscopy included the presence of fibers, linear covering trichomes, and glandular trichomes. Preliminary phytochemical screening confirmed the presence of different classes of phytoconstituents, such as glycosides, flavonoids, phenols, and triterpenoids. The DNA damage protection assay revealed that the crude methanolic extracts of these plants effectively protected human DNA from oxidative stress generated by free radicals of the oxidizing agent (Fenton’s reagent).
- 28 April 2025
- Published by University of Management and Technology in Currents in Pharmaceutical Research
- Vol. 3 (1) , 28-51
Open AccessPharmacognostic, Phytochemical, and DNA Protection Assays of Eclipta alba, Ageratum conyzoides, Calendula officinalis, and Conyza bonariensis
Asteraceae is the most famous family of ornamental flowering plants. Most of the plants included in this family have medicinal properties. The current research aimed to investigate the pharmacognostic and phytochemical standards of Eclipta alba L., Ageratum conyzoides L., Calendula officinalis L., and Conyza bonariensis L. to ensure their purity, safety, and efficacy as medicinal agents. The investigated parameters included pharmacognostic characterization, that is, powder microscopy, preliminary phytochemical analysis, physicochemical analysis, and in vitro DNA protection assay. The pharmacognostic characteristics evaluated via microscopy included the presence of fibers, linear covering trichomes, and glandular trichomes. Preliminary phytochemical screening confirmed the presence of different classes of phytoconstituents, such as glycosides, flavonoids, phenols, and triterpenoids. The DNA damage protection assay revealed that the crude methanolic extracts of these plants effectively protected human DNA from oxidative stress generated by free radicals of the oxidizing agent (Fenton’s reagent).